Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1K Sell
191
-12
-6% -$1.95K ﹤0.01% 151
2025
Q4
$39.6K Sell
203
-214
-51% -$51K ﹤0.01% 173
2025
Q3
$117K Sell
417
-237
-36% -$60.4K ﹤0.01% 138
2025
Q2
$143K Hold
654
﹤0.01% 131
2025
Q1
$91.4K Hold
654
﹤0.01% 142
2024
Q4
$109K Buy
654
+30
+5% +$5.33K ﹤0.01% 153
2024
Q3
$106K Buy
624
+53
+9% +$7.68K ﹤0.01% 156
2024
Q2
$80.6K Sell
571
-106
-16% -$13.2K ﹤0.01% 160
2024
Q1
$85K Buy
677
+223
+49% +$25.5K ﹤0.01% 162
2023
Q4
$47.9K Buy
+454
New +$49.5K ﹤0.01% 157

Other funds holding ORCL

Bellevue Group's ORCL Position: Q1 2026 in Review

Bellevue Group reduced its Oracle (ORCL) stake by 5.9% in Q1 2026, selling an estimated $1.95K and leaving 191 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #151.

Bellevue Group first reported a position in ORCL in Q4 2023 and has held it in 10 quarters since. The position peaked at $143K in Q2 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Bellevue Group held 191 shares of Oracle worth $28.1K as of Q1 2026.
  • Bellevue Group sold 12 Oracle shares in Q1 2026, an estimated $1.95K.
  • Oracle made up ﹤0.01% of Bellevue Group's portfolio in Q1 2026, its #151 holding.
  • Bellevue Group first reported a position in Oracle in Q4 2023 and has held it in 10 quarters since.
  • Bellevue Group's Oracle position peaked at $143K in Q2 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.